Imperial Innovations is streaming £5.1 million into newborn biotech Artios Pharma, giving the firm a 14.9 percent stake in its business.
News
Sanofi sues Merck for infringing Lantus patents
Sanofi is taking Merck & Co to court claiming that the firm has infringed 10 patents covering its best-selling insulin glargine products Lantus and Lantus SoloStar.
FDA OKs first Duchenne muscular dystrophy drug
The US Food and Drug Administration has granted a conditional approval to Sarepta’s Exondys 51, the first drug cleared to treat patients with Duchenne muscular dystrophy (DMD).
600 GP practices could close by 2020, warns RCGP
The Royal College of GPs is warning that patient safety could be at risk from a stream of practice closures driven by a “chronic shortage” of family doctors.
GSK names new chief executive
GlaxoSmithKline has announced that Emma Walmsley will take over from current chief executive Andrew Witty following his retirement at the end of March next year.
Stelara wins EU backing for Crohn’s indication
Advisors to the European Medicines Agency are backing approval of Janssen’s Stelara, bringing the drug closer to becoming the first interleukin-12/23 inhibitor licensed for Crohn’s disease.
NICE says no to expanding scope of Roche’s IPF drug
Patients in England and Wales with the lung scarring disease idiopathic pulmonary fibrosis will have to wait until their disease has worsened before getting routine NHS access to Roche’s Esbriet.
J&J snaps of Abbott’s eye unit for $4.36bn
Johnson & Johnson is buying Abbott’s eye health unit in a cash deal worth $4.36 billion, building on its presence in the area and marking its entry into cataract surgery.
Ten medicines leap towards EU approval
Ten new medicines have taken a giant leap closer to European Union approval after having won the backing of the Committee for Medicinal Products for Human Use.
Novartis’ siponimod hits targets in MS trial
Novartis has unveiled further findings from a late-stage trial of its experimental multiple sclerosis drug BAF312 (siponimod), showing that the drug cut the risk of disability progression in adults with secondary progressive forms of the disease.
International Clinical Researcher of the Year 2017: Entries are Open!
Invest in yourself and gain international recognition for your achievements. Entries for the International Clinical Researcher of the Year 2017 competition are now open.
Care rationing widespread in NHS, survey finds
The majority of doctors taking part in a survey for ITV News have admitted to rationing care on the NHS because of financial constraints.
DH introduces Bill for new drug pricing controls
The Department of Health has introduced a new Bill in parliament that will enable the government to limit the cost of unbranded medicines in case of unreasonable price increases.
Screening prevents 70 percent of cervical cancer deaths
Screening for cervical cancer prevents 70 percent of deaths from the disease, but this figure could be as high as 83 percent if all eligible women had regular smear tests, according to new research by Cancer Research UK, published in the British Journal of Cancer.
